GATA1 mutational analysis in chronic myeloid leukaemia.

GATA1 mutational analysis in chronic myeloid leukaemia.

Detalles Bibliográficos
Main Authors:	Halsey, C, Fisher, C, Strathdee, G, Gibson, B, Holyoake, T, Vyas, P, Graham, G
Formato:	Journal article
Idioma:	English
Publicado:	2007

Títulos similares

Analysis of GATA-1 mutations in chronic myeloid leukaemia.
por: Halsey, C, et al.
Publicado: (2006)

GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome
por: Garnett, C, et al.
Publicado: (2019)

How do Gata1 and cohesin gene mutations contribute to the development of myeloid leukaemia?
por: Garnett, C
Publicado: (2020)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
por: Reinhardt, K, et al.
Publicado: (2010)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
por: Reinhardt, K, et al.
Publicado: (2010)

FLT3‐targeted therapy restores GATA1 pathway function in NPM1/FLT3‐ITD mutated acute myeloid leukaemia
por: D Sorcini, et al.
Publicado: (2023-11-01)

Clonal structures of leukaemia stem cell populations in myeloid blast phase chronic myeloid leukaemia
por: Karamitros, D, et al.
Publicado: (2016)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
por: Alford, K, et al.
Publicado: (2011)

The Importance of Mutational Analysis in Chronic Myeloid Leukaemia for Treatment Choice
por: Hugues de Lavallade, et al.
Publicado: (2016-11-01)

Natural history of GATA-1 mutations in Down syndrome.
por: Ahmed, M, et al.
Publicado: (2003)

C/EBPalpha mutations in acute myeloid leukaemias.
por: Nerlov, C
Publicado: (2004)

Natural history of GATA1 mutations in Down syndrome.
por: Ahmed, M, et al.
Publicado: (2004)

Myelodysplastic syndrome due to somatic GATA1 mutation.
por: Freson, K, et al.
Publicado: (2004)

miR-1202 acts as anti-oncomiR in myeloid leukaemia by down-modulating GATA-1S expression
por: Raffaele Sessa, et al.
Publicado: (2024-02-01)

Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.
por: Tunstall-Pedoe, O, et al.
Publicado: (2008)

Unprecedented behaviour of chronic myeloid leukaemia
por: Balambika RG, et al.
Publicado: (2016-07-01)

Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia.
por: Foroni, L, et al.
Publicado: (2011)

Chronic myeloid leukaemia with marked thrombocytosis
por: Jun Ooi, et al.
Publicado: (2021-02-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
por: R Edlin, et al.
Publicado: (2010-05-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
por: R Edlin, et al.
Publicado: (2010-05-01)

GATA2 mutations and overexpression in pediatric acute myeloid leukemia
por: Zhenzhen Yang, et al.
Publicado: (2019-08-01)

Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation
por: Robert R. West, et al.
Publicado: (2014-02-01)

A Myelodysplastic Syndrome Associated with a Clonal GATA1 Mutation.
por: Freson, K, et al.
Publicado: (2008)

Transcriptional regulation of GATA1
por: Drissen, R, et al.
Publicado: (2007)

Rapid parallel acquisition of somatic mutations after NPM1 in acute myeloid leukaemia evolution
por: Grove, C, et al.
Publicado: (2016)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
por: Boultwood, J, et al.
Publicado: (2004)

Slovenian recommendations for the management of chronic myeloid leukaemia
por: Irena Preložnik Zupan, et al.
Publicado: (2018-04-01)

Two ophthalmic presentations of chronic myeloid leukaemia
por: Miles Kiernan, et al.
Publicado: (2022-08-01)

Deletion of the major GATA1 enhancer HS 1 does not affect eosinophil GATA1 expression and eosinophil differentiation.
por: Guyot, B, et al.
Publicado: (2004)

PLATELET DYSFUNCTION AND MDS FEATURES DUE TO NOVEL SOMATIC GATA1 MUTATION
por: Freson, K, et al.
Publicado: (2010)

Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK
por: Cross, N, et al.
Publicado: (2018)

Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.
por: Heald, B, et al.
Publicado: (2007)

EVI1 expression in acute myeloid leukaemia.
por: Langabeer, SE, et al.
Publicado: (2001)

GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1.
por: Kuhl, C, et al.
Publicado: (2005)

Harnessing the graft-versus-leukaemia effect in acute myeloid leukaemia
por: Sweeney, C
Publicado: (2021)

Germline DNMT3A mutation in familial acute myeloid leukaemia
por: Courtney D. DiNardo, et al.
Publicado: (2021-05-01)

GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1
por: Kuhl, C, et al.
Publicado: (2005)

A rare case of an elderly male with progression to chronic myeloid leukaemia secondary to chronic lymphocytic leukaemia
por: Sakditad Saowapa, et al.
Publicado: (2024-03-01)

GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies
por: Xinan Wang, et al.
Publicado: (2015-10-01)

The genetics of chronic myeloid leukaemia and recent advancements in therapy
por: Alexander Wellington
Publicado: (2022-06-01)